fda warning letters glp-1 october 2025 news September 15, 2025: Telehealth company

GLP-1 and exenatide all correct each of those defects stimulating insulin secretion in a glucose-dependent fashion, and specifically, increasing the first-phase insulin response

However, patients may be eligible to use HSA or FSA funds depending on their provider's reimbursement guidelines

Ref, reference

This shift opens a meaningful growth opportunity for CPG manufacturers ready to reframe indulgence as functional. The Food Institute Podcast At SIAL Canada 2026 in Montreal, Food Institute VP of Content and Insights Chris Campbell sat down with Mathieu Brisson, Global Sales Lead at Prestige Maple , to discuss how the company is transforming maple products for a rapidly evolving global food and beverage market.

REWIND, Researching Cardiovascular Events with A Weekly Incretin in Diabetes